The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

McKinsey & Company Inc., a management consulting firm, recently agreed to pay $650 million to resolve a civil and criminal investigation into consulting work performed by the firm with opioids ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid crisis. This comes after a previous deal was rejected by the ...

The Score is a weekly review of the biggest stock moves and the news that drove them ... a similar suit against Walgreens ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

The latest health briefs reveal Novo Nordisk's promising obesity treatment and a $7.4 billion Purdue Pharma settlement over ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Members of the family who own OxyContin maker Purdue Pharma and the company itself agreed to pay up to $7.4 billion in a new ...

The Sackler family, owners of Purdue Pharma, reached a $7.4 billion settlement to resolve mass opioid litigation. The Department of Justice filed a civil lawsuit against Walgreens over allegations it ...

Purdue Pharma's Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday.